ArticleiScience2024

ISG12a promotes immunotherapy of HBV-associated hepatocellular carcinoma through blocking TRIM21/AKT/β-catenin/PD-L1 axis.

Rilin Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.